EN
HI
Jenburkt Pharmaceuticals Chart
Jenburkt Pharmaceuticals Share Key Metrics
Volume
1480.00
Market Cap
503.80 CR
LTQ@LTP
18@1141.55
ATP
1145.14
Var Margin
18.86 %
Circuit Range
927.55-1391.25
Delivery %
47.59 %
Value
16.95 L
ASM/GSM
No
Market Lot
1
Summary
Jenburkt Pharmaceuticals share price is ₹1141.55 as of 2 Jun, 2026. The stock Jenburkt Pharmaceuticals intraday movement has stayed between ₹1135.00 and ₹1170.95, while on a 52-week basis,Jenburkt Pharmaceuticals price 52 week high is ₹1410.00 & its 52 week low is ₹944.00.
In terms of trading activity, Jenburkt Pharmaceuticals has recorded a volume of 1480 shares, The Jenburkt Pharmaceuticals has a market cap of ₹4413300 CR. The stock’s Average Traded Price (ATP) stands at ₹1145.14, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 18 @ ₹1141.55.
Jenburkt Pharmaceuticals operates within a circuit range of ₹927.55 – ₹1391.25, with a Value of ₹16.95 L. The Delivery Percentage for the day is 47.59%. Additionally, Jenburkt Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Jenburkt Pharmaceuticals Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Jenburkt Pharmaceuticals Resistance and Support
Pivot 1162.37
Resistance
First Resistance
1172.74
Second Resistance
1186.07
Third Resistance
1196.44
Support
First Support
1149.04
Second Support
1138.67
Third Support
1125.34
Jenburkt Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-05 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
Jenburkt Pharmaceuticals News
Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off Date
Jenburkt Pharmaceuticals fixed August 28, 2026, as record date for dividend payment for FY26. This date also determines e-voting eligibility for the 41st Annual General Meeting scheduled on September 04, 2026.
May 06 2026 14:59:30
Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management
Jenburkt Pharmaceuticals re-appointed Shri Dilip H. Bhuta as Whole Time Director and CFO for a five-year term, effective April 1, 2027 to March 31, 2032. This re-appointment provides leadership stability and continuity.
May 05 2026 19:46:56
Read More
Jenburkt Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish U Bhuta | Chairman & Managing Director |
| Dilip H Bhuta | Whole Time Director & Chief Financial Officer |
Jenburkt Pharmaceuticals FAQs
The Buying Price of Jenburkt Pharmaceuticals share is 1141.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jenburkt Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jenburkt Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jenburkt Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jenburkt Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jenburkt Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jenburkt Pharmaceuticals is 503.80 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jenburkt Pharmaceuticals share price is 1410.00 & 944.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jenburkt Pharmaceuticals belongs to the Healthcare sector.
